Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3042]
News [6141]
Articles [120]
Editorials [18]
Conferences [181]
elearning [32]
Most NIH-sponsored trials slow to publish, many aren’t published, most fail to report data
Most NIH-sponsored trials slow to publish, many aren’t published, most fail to report data
FDA bolsters doxorubicin and methotrexate
FDA bolsters doxorubicin and methotrexate
NICE rejects three drugs for advanced colorectal cancer in the UK
NICE rejects three drugs for advanced colorectal cancer in the UK
FDA revokes Avastin approval for breast cancer patients
FDA revokes Avastin approval for breast cancer patients
FDA nod for erwinia chrysanthemi for certain ALL patients
FDA nod for erwinia chrysanthemi for certain ALL patients
Pemetrexed receives EC approval as a continuation maintenance therapy for NSCLC
Pemetrexed receives EC approval as a continuation maintenance therapy for NSCLC
Zytiga approved in the EU for metastatic castration-resistant prostate cancer
Zytiga approved in the EU for metastatic castration-resistant prostate cancer
NICE recommends nilotinib for CML patients resistant to imatinib
NICE recommends nilotinib for CML patients resistant to imatinib
NICE: final guidance recommends bortezomib and thalidomide in multiple myleoma
NICE: final guidance recommends bortezomib and thalidomide in multiple myleoma
EU go ahead for abiraterone acetate for metastatic castration resistant prostate cancer
EU go ahead for abiraterone acetate for metastatic castration resistant prostate cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation